ALB

Business Context and Reporting Period

Company: Albemarle Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2009
Business Overview: Albemarle is a global developer, manufacturer, and marketer of highly-engineered specialty chemicals. Operations are managed across three segments: Polymer Solutions (flame retardants, stabilizers, curatives), Catalysts (refinery and polyolefin catalysts), and Fine Chemicals (performance chemicals, pharmaceutical intermediates, and custom chemistry services). The company operates 45 facilities globally and serves approximately 3,000 customers in over 100 countries.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 19% primarily due to a 12% decline in volumes and a 5% decline in price/mix across all segments, driven by the global economic downturn and softness in consumer electronics, automotive, and construction sectors.
• Cost Reductions: Operating costs were approximately $100 million lower than 2008 due to restructuring programs and process optimization. SG&A expenses decreased 17% and R&D expenses decreased 10%.
• Special Items:
  • Port de Bouc Disposition: Incurred $12.4 million in charges in 2009 (vs. $38.5 million in 2008) related to the final settlement of the divestiture of the France facility.
  • Restructuring: Incurred $11.6 million in charges in 2009 (vs. $25.8 million in 2008) for workforce reductions and asset write-offs.
• Tax Benefit: The effective tax rate was negative (4.4%) in 2009, compared to (3.6%) in 2008, largely due to a $22.8 million tax benefit from the settlement of IRS audits for tax years 2005-2007.

Guidance, Outlook, and Risks

2010 Outlook:

• Polymer Solutions: Expected profitability improvement driven by restructuring and stronger consumer electronics demand. New antioxidant capacity in Shanghai to come online in Q1 2010.
• Catalysts: Revenue growth expected from delayed HPC refills, new product introductions, and global growth in polyolefin catalysts. Focus on emerging markets (Asia, Brazil, Middle East).
• Fine Chemicals: Stable growth expected in performance chemicals; continued expansion of fine chemistry services.
• Corporate: Global effective tax rate expected to range between 18% and 20%. Increased pension expense of approximately $15 million anticipated.

Key Risks and Contingencies:

• Regulatory: Ongoing scrutiny of brominated flame retardants (e.g., decabromodiphenyl ether bans in Vermont, Oregon, and EU). REACH regulations in Europe impose significant compliance costs.
• Raw Materials: Volatility in raw material costs (e.g., molybdenum, bromine) and energy prices. Inability to pass through cost increases could impact margins.
• Environmental: Potential liabilities for hazardous waste site remediation. Management believes outstanding liabilities are not material but future expenditures could be unforeseen.
• Joint Ventures: Risks associated with partners failing to fulfill obligations in high-risk regions (Middle East, South America).

Investor Verification Checklist

• Volume Recovery: Verify if the 12% volume decline in 2009 is reversing in 2010, particularly in the cyclical consumer electronics and automotive sectors.
• Restructuring Costs: Confirm the final cost of the Bergheim, Germany restructuring program (estimated $7-10 million) and its impact on 2010 earnings.
• Tax Rate Normalization: Assess the sustainability of the negative effective tax rate; the 2010 guidance suggests a return to a 18-20% rate, which will significantly impact net income.
• Regulatory Impact: Monitor the timeline and scope of bans on decabromodiphenyl ether and hexabromocyclododecane (HBCD) in key markets, as these products represent a portion of sales.
• Debt Covenants: Verify continued compliance with the March 2007 credit agreement covenants, specifically the funded debt to EBITDA ratio (max 3.5x).